skip to Main Content

Translational research in viral hepatitis:
Addressing the gaps for cure

23-25 January 2020

Athens, Greece

Dear colleagues,

On behalf of the European Association for the Study of the Liver, we are delighted to welcome you in Athens to attend the EASL monothematic conference “Translational research in viral hepatitis: Addressing the gaps for cure”.

This event will focus on translational aspects of viral hepatitis research with the aim of bridging research at the bench with clinical investigation and applications. The program will focus on chronic HBV and HCV infections, but also on HDV and HEV infections, with special emphasis on new developments in the fields of viral replication, pathogenesis, immunology, cohort studies, and application to new therapeutic approaches to cure these infections.

Young scientists are particularly encouraged to participate and will have the opportunity to present their original results during a specific devoted session.

The format is intended to generate active interactions and discussions between basic scientists and clinicians, and to foster future collaborative efforts to better understand the pathogenesis of these viral infections, identify novel biomarkers and antiviral targets, and to improve patient management.

We sincerely hope that you will enjoy this conference and have a great time in Athens.

With warm regards,

Prof. Darius Moradpour

Prof. Robert Thimme

Prof. Fabien Zoulim


Why attend?
  • Meet the best international experts in viral hepatitis in workshop format that will foster discussions and interactions
  • State of the art lectures on the most recent advances in the rapidly evolving field of viral hepatitis
Who should attend?
  • Scientists and physicians from both the academic and industry sectors interested in viral hepatitis pathogenesis and cure
  • Young scientists interested in viral hepatitis